East Hanover (United States)

Type: City
Name: East Hanover (United States)
Country: United States
Latitude: 40.82
Longitude: -74.370003
population: 12,194
First reported 20 hours ago - Updated 20 hours ago - 1 reports

Parshas Re’eh

New Jersey resident Herman “Hy” Goldman still showed up for work on Monday.  The reason why Mr. Goldman’s day at work is noteworthy is because this past weekend he celebrated his 101st birthday.  Aside from a brief absence to serve in the U.S. Army in ... [Published JewishinStLouis - 20 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

Mortgage CUSO Makes Inc. Magazine's Fastest Growing List

Symbionce Financial Solutions LLC, a mortgage services firm, was the only CUSO to make Inc. magazine’s 500|5000 list, a ranking of the nation's fastest-growing private companies.Those selected for the 2014 list were ranked according to percentage revenue ... [Published Credit Union Times - 21 hours ago]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Patent Issued for Safety Pen Needle Assembly Having Shield for Non-Patient End

By a News Reporter-Staff News Editor at Journal of Engineering -- According to news reporting originating from Alexandria, Virginia , by VerticalNews journalists, a patent by the inventors Zaiken, Eliot ( Covington, GA ); Richards, Stephen ( Holdrege, ... [Published 4 Traders - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

BECTON DICKINSON : Patent Issued for Angled Retracting Sheath for Safety Needle

By a News Reporter-Staff News Editor at Journal of Engineering -- From Alexandria, Virginia , VerticalNews journalists report that a patent by the inventors Wong, Andrew ( East Hanover, NJ ); Zachek, Matthew ( Ridgewood, NJ ), filed on March 11, 2013 ... [Published 4 Traders - Aug 21 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

101-year-old working man has advice for you

EAST HANOVER, N.J. - "What am I going to do, sit around and grow old?"That's what New Jersey resident Herman Goldman rhetorically asked a television reporter who was doing a story on his 101st birthday this month.  There's apparently no quit in this ... [Published NewsNet 5 - Aug 19 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

NEW FINDINGS FROM NOVARTIS DESCRIBE ADVANCES IN DEMENTIA (LONG-TERM SAFETY OF RIVASTIGMINE IN PARKINSON DISEASE DEMENTIA : An Open-Label, Randomized...

New Findings from Novartis Describe Advances in Dementia (Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study)By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Current study results on Dementia ... [Published 4 Traders - Aug 14 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Novartis loses new bid to dismiss U.S. lawsuit over kickbacks

U.S. District Judge Colleen McMahon allowed the government to continue its False Claims Act case against the Swiss drugmaker over claims submitted to Medicare and some state Medicaid programs for Myfortic, used by patients with kidney transplants, and ... [Published NewsRT.co.uk - Aug 08 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Study Data from Novartis Update Knowledge of Heart Failure (An International Survey to Assess Referral Thresholds for Destination Therapy in...

Study Data from Novartis Update Knowledge of Heart Failure ( An International Survey to Assess Referral Thresholds for Destination Therapy in Non-Inotrope-Dependent Patients: Results of the CONSENSUS-DT Study)By a News Reporter-Staff News Editor at Clinical ... [Published 4 Traders - Aug 06 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Reports Summarize Multiple Sclerosis Study Results from Novartis (Characteristics influencing therapy switch behavior after suboptimal response to...

Reports Summarize Multiple Sclerosis Study Results from Novartis (Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis)By a News Reporter-Staff News Editor at Clinical ... [Published 4 Traders - Jul 23 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Report: Development IT hit hard in Novartis cutbacks

Over the first few months of 2014, Novartis ($NVS) quietly began laying off workers, shedding an estimated 3,000 jobs in four months. Now BioSpace has provided details of where the ax has fallen and why, with development IT teams suffering heavy job ... [Published Fierce Biotech IT - Jul 18 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

New Findings from Novartis Update Understanding of Clinical Trials and Studies (Efficacy of vildagliptin versus sulfonylureas as add-on therapy to...

New Findings from Novartis Update Understanding of Clinical Trials and Studies (Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies)By a News Reporter-Staff ... [Published 4 Traders - Jul 16 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 1 reports

Novartis personalized cell therapy CTL019 receives FDA Breakthrough Therapy designation

EAST HANOVER, N.J., July 7, 2014 /PRNewswire/ -- Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment ... [Published PR Newswire: Policy & Public Interest - Jul 07 2014]

Quotes

"In a second aspect of the subject invention, a safety pen needle assembly is provided herein which includes a hub; a needle fixed to the hub having a distal end, formed for insertion into a patient, and a proximal end; a shield; a biasing means disposed to urge the shield from a first position to a second position; and, at least one pivoting locking finger on the hub, the pivoting locking finger being deflectable from a first state to a second state. With the locking finger being in a first state, the locking finger interferingly engages the shield so as to restrict movement thereof. The locking finger in the first state retains the shield in its first position with the proximal end of the needle being exposed. With the locking finger being in the second state, the locking finger does not interferingly engage with the shield. As such, the shield is permitted to be urged proximally to the second position by the biasing means. In the second position, the shield covers the proximal end of the needle. Advantageously, with the subject invention, a mechanism is provided for shielding a proximal, or non-patient, end of a pen needle, particularly after use."
"In one or more embodiments, the graduated injection depth gauge may be printed onto an outer surface of the retractable sheath. In another embodiment, the graduated injection depth gauge may be engraved, etched, embossed, debossed by molding or formed onto an outer surface of the retractable sheath."

More Content

All (23) | News (21) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Parshas Re’eh [Published JewishinStLouis - 20 hours ago]
Mortgage CUSO Makes Inc. Magazine's Fastest Gro... [Published Credit Union Times - 21 hours ago]
Patent Issued for Safety Pen Needle Assembly Ha... [Published 4 Traders - Aug 21 2014]
BECTON DICKINSON : Patent Issued for Angled Ret... [Published 4 Traders - Aug 21 2014]
101-year-old working man has advice for you [Published NewsNet 5 - Aug 19 2014]
NEW FINDINGS FROM NOVARTIS DESCRIBE ADVANCES IN... [Published 4 Traders - Aug 14 2014]
Stuart named studio director at MADGI [Published New York Real Estate Journal - Aug 12 2014]
Novartis loses new bid to dismiss U.S. lawsuit ... [Published NewsRT.co.uk - Aug 08 2014]
Novartis loses new bid to dismiss U.S. lawsuit ... [Published Clusterstock - Aug 08 2014]
Study Data from Novartis Update Knowledge of He... [Published 4 Traders - Aug 06 2014]
MAGDI hires David Stuart, AIA, as Studio Direct... [Published Building Design Construction - Jul 29 2014]
Reports Summarize Multiple Sclerosis Study Resu... [Published 4 Traders - Jul 23 2014]
Report: Development IT hit hard in Novartis cut... [Published Fierce Biotech IT - Jul 18 2014]
New Findings from Novartis Update Understanding... [Published 4 Traders - Jul 16 2014]
Latest Alzheimer's clinical trial will involve ... [Published Star Ledger - Jul 15 2014]
Novartis AG Layoffs Announced: More Cuts May Be... [Published BioSpace - Jul 14 2014]
The List: More than Mail, ZIP Code Used to Trac... [Published NJ Spotlight - Jul 14 2014]
Police blotter, 7/13: Armed robberies in Palmyr... [Published Lebanon Daily News - Jul 14 2014]
Novartis personalized cell therapy CTL019 recei... [Published PR Newswire: Policy & Public Interest - Jul 07 2014]
Protection 1 Partners With Wounded Warriors Fam... [Published PRWeb - Jun 30 2014]
Novartis gains FDA approval for Zykadia first t... [Published BioPortfolio - Apr 29 2014]
Tissue engineering methods and compositions [Published PharmCast - Apr 22 2014]
Mondelez International to Invest $130 Million i... [Published PR Newswire - Feb 06 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Novartis loses new bid to dismiss U.S. lawsuit ... [Published Clusterstock - Aug 08 2014]
<p><img class="float_right" src="http://static6.businessinsider.com/image/53c78ada5afbd329788b4567-450-300/drugmaker-novartis-to-eke-out-more-cost-savings-to-lift-margins.jpg" border="0" alt="The logo of Swiss drugmaker Novartis is seen at its headquarters ...
Novartis personalized cell therapy CTL019 recei... [Published PR Newswire: Policy & Public Interest - Jul 07 2014]
EAST HANOVER, N.J., July 7, 2014 /PRNewswire/ -- Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.